|
13 Jul 2020 |
Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV
|
|
09 Jul 2020 |
Zymeworks Announces New Multispecific Antibody Collaboration with Merck
|
|
09 Jul 2020 |
ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics
|
|
09 Jul 2020 |
Foghorn® Therapeutics Announces Collaboration with Merck to Discover and Develop Novel Oncology Therapeutics Against Transcription Factor Target
|
|
07 Jul 2020 |
Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
|
|
07 Jul 2020 |
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
|
|
06 Jul 2020 |
Dragonfly Therapeutics Announces New Research Collaboration with Bristol Myers Squibb to Develop Novel Therapeutic Candidates for Multiple Sclerosis and Neuro-inflammation Target
|
|
02 Jul 2020 |
Merck and Ridgeback Bio Announce Closing of Collaboration and Licensing Transaction
|
|
01 Jul 2020 |
Aligos Therapeutics and KU Leuven Announce Collaboration for the Development of a Therapeutic Candidate Targeting Coronavirus
|
|
01 Jul 2020 |
Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extracellular Vesicles Platform
|
|
30 Jun 2020 |
Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance
|
|
29 Jun 2020 |
VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical
|
|
26 Jun 2020 |
Sosei Heptares and AbbVie Announce New Discovery Collaboration Targeting Inflammatory Diseases
|
|
24 Jun 2020 |
Yumanity Therapeutics Announces Strategic Research Collaboration and License Agreement with Merck Focused on Accelerating the Development of New Treatments for Neurodegenerative Diseases
|
|
24 Jun 2020 |
La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.
|
|
22 Jun 2020 |
Minerva Biotechnologies Announces License Agreement with Memorial Sloan Kettering Cancer Center for 1XX Technology
|
|
18 Jun 2020 |
Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
|
|
18 Jun 2020 |
Rexahn and Ocuphire Enter into Definitive Merger Agreement
|
|
17 Jun 2020 |
Ubiquigent Continues Drug Discovery Collaboration With Bristol Myers Squibb
|
|
16 Jun 2020 |
Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
|
|
16 Jun 2020 |
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
|
|
15 Jun 2020 |
Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies
|
|
13 Jun 2020 |
CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) Congress
|
|
11 Jun 2020 |
Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies
|
|
11 Jun 2020 |
Novo Nordisk to acquire Corvidia Therapeutics and expand presence in cardiovascular disease
|
